|
Volumn 80, Issue 3, 2001, Pages
|
The future of monoclonal antibody engineering
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
RECOMBINANT ANTIBODY;
ANTIBODY PRODUCTION;
ANTIGEN BINDING;
B CELL LYMPHOMA;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
CONFERENCE PAPER;
GENETIC ENGINEERING;
HUMAN;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RADIOIMMUNOTHERAPY;
RECOMBINANT DNA TECHNOLOGY;
ANTIBODIES, MONOCLONAL;
DRUG DESIGN;
FORECASTING;
GENES, IMMUNOGLOBULIN;
HUMANS;
IMMUNOGLOBULIN VARIABLE REGION;
LYMPHOMA;
PROTEIN ENGINEERING;
RADIOIMMUNOTHERAPY;
RECOMBINANT FUSION PROTEINS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035204383
PISSN: 09458077
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (19)
|